Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents

BACKGROUND: Cholangiocarcinoma (CCA) is highly resistant to most of the known chemotherapeutic treatments. NAD(P)H-quinone oxidoreductase 1 (NQO1) is an antioxidant/detoxifying enzyme recently recognized as an important contributor to chemoresistance in some human cancers. However, the contribution...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeekpudsa, Ponsilp, Kukongviriyapan, Veerapol, Senggunprai, Laddawan, Sripa, Banchob, Prawan, Auemduan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922744/
https://www.ncbi.nlm.nih.gov/pubmed/24460787
http://dx.doi.org/10.1186/1756-9966-33-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922744/
https://www.ncbi.nlm.nih.gov/pubmed/24460787
http://dx.doi.org/10.1186/1756-9966-33-11

Ejemplares similares